Nicholas Investment Partners, LP

Position in RVMD — Revolution Medicines, Inc.

CIK 1389574 RANCHO SANTA FE, CA

Position in RVMD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$45,807,564

+$20,409,171 QoQ

Shares Held

244,594

-6.3% QoQ

Ownership

0.114%

of shares outstanding

% of Portfolio

2.94%

of 13F equity value

Holder Rank

#92

of 685 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Nicholas Investment Partners, LP holds $271,971,066 across 20 Biotechnology names. RVMD ranks #1 (16.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc. This page	244,594	$45,807,564
2	AXSM	Axsome Therapeutics, Inc.	98,974	$24,225,865
3	XENE	Xenon Pharmaceuticals Inc.	395,844	$23,893,143
4	BBIO	BridgeBio Pharma, Inc.	311,494	$23,200,073
5	MIRM	Mirum Pharmaceuticals, Inc.	172,695	$20,217,403
6	ELVN	Enliven Therapeutics, Inc.	391,529	$19,870,096
7	DNTH	Dianthus Therapeutics, Inc. /DE/	186,769	$18,206,242
8	CYTK	Cytokinetics Inc	209,071	$17,810,758

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$45,807,564	244,594	-6.3%	Shares	Sole	2026-08-14
2026-03-31	$25,398,393	261,166	-17.8%	Shares	Sole	2026-05-15
2025-12-31	$25,305,681	317,711	+18.6%	Shares	Sole	2026-02-13
2025-09-30	$12,511,443	267,911	+136.8%	Shares	Sole	2025-11-14
2025-06-30	$4,161,905	113,126	+85.1%	Shares	Sole	2025-08-14
2025-03-31	$2,161,309	61,123	-27.9%	Shares	Sole	2025-05-15
2024-12-31	$3,706,046	84,729	+36.0%	Shares	Sole	2025-02-14
2024-09-30	$2,825,305	62,300	-60.6%	Shares	Sole	2024-11-12
2024-06-30	$6,137,102	158,132	—	Shares	Sole	2024-08-08
No filing history on record for this holder in this stock.